Open Access. Powered by Scholars. Published by Universities.®
Veterinary Toxicology and Pharmacology Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- 8 ng/mL (1)
- Analgesia (1)
- Bisphosphonates (1)
- Bone Remodeling (1)
- Buprenorphine (1)
-
- Chlorhexidine (1)
- Chondrotoxicity (1)
- Dog (1)
- Environmental presence (1)
- Equine (1)
- Folliculitis (1)
- Gabapentin (1)
- Horse (1)
- Horses (1)
- LPS (1)
- Mass Spectrometry (1)
- Mousse (1)
- Pharmacodynamics (1)
- Pharmacokinetics (1)
- Plasma concentration (1)
- Protein Biomarkers (1)
- Pyoderma (1)
- Screening Limit of Detection (1)
- Staphylococcus pseudintermedius (1)
- Publication
- Publication Type
Articles 1 - 4 of 4
Full-Text Articles in Veterinary Toxicology and Pharmacology
Gabapentin, A Human Therapeutic Medication And An Environmental Substance Transferring At Trace Levels To Horses: A Case Report., Kimberly Brewer, Jacob Machin, George Maylin, Clara Fenger, Abelardo Morales-Briceño, Thomas Tobin
Gabapentin, A Human Therapeutic Medication And An Environmental Substance Transferring At Trace Levels To Horses: A Case Report., Kimberly Brewer, Jacob Machin, George Maylin, Clara Fenger, Abelardo Morales-Briceño, Thomas Tobin
Maxwell H. Gluck Equine Research Center Faculty Publications
Gabapentin, 1-(Aminomethyl)cyclohexaneacetic acid, MW 171.240, is a frequently prescribed high dose human medication that is also used recreationally. Gabapentin is orally absorbed; the dose can be 3,000 mg/day and it is excreted essentially unchanged in urine. Gabapentin is stable in the environment and routinely detected in urban wastewater. Gabapentin randomly transfers from humans to racing horses and is at times detected at pharmacologically ineffective / trace level concentrations in equine plasma and urine. In Ohio racing between January 2019 and July 2020,18 Gabapentin identifications, all less than 2 ng/ml in plasma, were reported. These identifications were ongoing because the horsemen …
Evaluation Of Residual Antibacterial Effects On Canine Skin Surface And Hairs Following Treatment With Five Commercial Mousse Products Against Staphylococcus Pseudintermedius In Vitro, Chi-Yen Wu
LSU Master's Theses
Topical products are essential treatments for canine superficial bacterial folliculitis. However, studies for commercial products typically evaluate antibacterial effects on hairs rather than the skin surface. In addition, the interference from the hair length has not been evaluated in these studies. Therefore, the study objective for this study was to evaluate the residual antibacterial effects of five mousse products, (1) 2% chlorhexidine and 2% miconazole, (2) 0.05% phytosphingosine, (3) 2% salicylic acid and 10% ethyl lactate, (4) 3% chlorhexidine and 0.5% climbazole, and (5) 2% chlorhexidine and 1% ketoconazole on both the skin surface and hairs in both short- and …
Intra-Articular Buprenorphine In Horses, Gabriel Castro-Cuellar Dr
Intra-Articular Buprenorphine In Horses, Gabriel Castro-Cuellar Dr
LSU Master's Theses
Opioid drugs have the potential of provide local analgesia in inflamed joints. To date, morphine is the only opioid that has been tested for intra-articular (IA) administration in horses. Having an alternative drug, other than morphine, could widen the therapeutic options, particularly in cases of drug shortages or inaccessibility to specific drugs. The work presented in this dissertation reports the cytotoxic effects of buprenorphine on cultured equine chondrocytes, and the pharmacokinetic, pharmacodynamic and analgesic effects, of IA administered buprenorphine in horses with experimentally induced synovitis.
To evaluate the potential cytotoxic effects on equine cartilage, chondrocytes were obtained from normal equine …
Identifying Bisphosphonate Protein Biomarkers In Equine Sera Using Mass Spectrometry Methods, Malinda Jayne Alison Porter
Identifying Bisphosphonate Protein Biomarkers In Equine Sera Using Mass Spectrometry Methods, Malinda Jayne Alison Porter
Theses and Dissertations--Veterinary Science
Bone resorptive diseases affect humans and horses, alike. Examples of these diseases include osteoporosis, Paget’s disease, and osteogenesis imperfecta in humans, and navicular disease in the horse (Mitchell et al., 2019; Suva et al., 2021). Bisphosphonates are used to treat these diseases, and may remain in the bone for several years after administration, demonstrating the need for newer drug testing methods.
The purpose of the discovery phase of this study was to use blood samples of in-training horses which had been given an initial administration of the bisphosphonate tiludronate and identify protein biomarkers that changed in response to this class …